82 FR 38697 - National Institute on Drug Abuse; Notice of Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 156 (August 15, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 156 (August 15, 2017)
| Page Range | 38697-38697 | |
| FR Document | 2017-17156 |
[Federal Register Volume 82, Number 156 (Tuesday, August 15, 2017)] [Notices] [Page 38697] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-17156] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Drug Abuse. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Drug Abuse. Date: September 6, 2017. Closed: 9:00 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Open: 10:30 a.m. to 5:00 p.m. Agenda: This portion of the meeting will be open to the public for announcements and reports of administrative, legislative, and program developments in the drug abuse field. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of Extramural Research, Office of the Director, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC 9591, Rockville, MD 20892, 301-443-6487, [email protected]. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: August 9, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-17156 Filed 8-14-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices 38697
Training; 93.143, NIEHS Superfund Office of the Director, National Institute on Date: September 12, 2017.
Hazardous Substances—Basic Research and Drug Abuse, NIH, DHHS, 6001 Executive Time: 12:00 p.m. to 4:00 p.m.
Education; 93.894, Resources and Manpower Boulevard, NSC, Room 5274, MSC 9591, Agenda: To review and evaluate grant
Development in the Environmental Health Rockville, MD 20892, 301–443–6487, applications.
Sciences; 93.113, Biological Response to sweiss@nida.nih.gov. Place: National Institutes of Health, 6701
Environmental Health Hazards; 93.114, Any member of the public interested in Rockledge Drive, Bethesda, MD 20892
Applied Toxicological Research and Testing, presenting oral comments to the committee (Telephone Conference Call).
National Institutes of Health, HHS) may notify the Contact Person listed on this Contact Person: Tasmeen Weik, DRPH,
Dated: August 9, 2017. notice at least 10 days in advance of the MPH, Scientific Review Officer, Center for
meeting. Interested individuals and Scientific Review, National Institutes of
Natasha M. Copeland,
representatives of organizations may submit Health, 6701 Rockledge Drive, Room 3141,
Program Analyst, Office of Federal Advisory a letter of intent, a brief description of the Bethesda, MD 20892, 301–827–6480, weikts@
Committee Policy. organization represented, and a short mail.nih.gov.
[FR Doc. 2017–17157 Filed 8–14–17; 8:45 am] description of the oral presentation. Only one (Catalogue of Federal Domestic Assistance
BILLING CODE 4140–01–P representative of an organization may be Program Nos. 93.306, Comparative Medicine;
allowed to present oral comments and if 93.333, Clinical Research, 93.306, 93.333,
accepted by the committee, presentations 93.337, 93.393–93.396, 93.837–93.844,
DEPARTMENT OF HEALTH AND may be limited to five minutes. Both printed 93.846–93.878, 93.892, 93.893, National
and electronic copies are requested for the Institutes of Health, HHS)
HUMAN SERVICES record. In addition, any interested person
may file written comments with the Dated: August 9, 2017.
National Institutes of Health committee by forwarding their statement to Natasha M. Copeland,
the Contact Person listed on this notice. The Program Analyst, Office of Federal Advisory
National Institute on Drug Abuse; statement should include the name, address,
Notice of Meeting Committee Policy.
telephone number and when applicable, the
business or professional affiliation of the [FR Doc. 2017–17154 Filed 8–14–17; 8:45 am]
Pursuant to section 10(d) of the
interested person. BILLING CODE 4140–01–P
Federal Advisory Committee Act, as Information is also available on the
amended, notice is hereby given of a Institute’s/Center’s home page:
meeting of the National Advisory www.drugabuse.gov/NACDA/
Council on Drug Abuse. The meeting DEPARTMENT OF HOMELAND
NACDAHome.html, where an agenda and
will be open to the public as indicated any additional information for the meeting
SECURITY
below, with attendance limited to space will be posted when available.
Federal Emergency Management
available. Individuals who plan to (Catalogue of Federal Domestic Assistance
Agency
attend and need special assistance, such Program Nos.: 93.279, Drug Abuse and
as sign language interpretation or other Addiction Research Programs, National [Docket ID FEMA–2017–0002; Internal
reasonable accommodations, should Institutes of Health, HHS) Agency Docket No. FEMA–B–1739]
notify the Contact Person listed below Dated: August 9, 2017.
in advance of the meeting. Natasha M. Copeland,
Changes in Flood Hazard
The meeting will be closed to the Determinations
Program Analyst, Office of Federal Advisory
public in accordance with the Committee Policy. AGENCY: Federal Emergency
provisions set forth in sections [FR Doc. 2017–17156 Filed 8–14–17; 8:45 am] Management Agency, DHS.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P ACTION: Notice.
as amended. The grant applications
and/or contract proposals and the SUMMARY: This notice lists communities
discussions could disclose confidential DEPARTMENT OF HEALTH AND where the addition or modification of
trade secrets or commercial property HUMAN SERVICES Base Flood Elevations (BFEs), base flood
such as patentable material, and depths, Special Flood Hazard Area
personal information concerning National Institutes of Health (SFHA) boundaries or zone
individuals associated with the grant designations, or the regulatory floodway
applications and/or contract proposals, Center for Scientific Review; Notice of (hereinafter referred to as flood hazard
the disclosure of which would Closed Meeting determinations), as shown on the Flood
constitute a clearly unwarranted Pursuant to section 10(d) of the Insurance Rate Maps (FIRMs), and
invasion of personal privacy. Federal Advisory Committee Act, as where applicable, in the supporting
Name of Committee: National Advisory amended, notice is hereby given of the Flood Insurance Study (FIS) reports,
Council on Drug Abuse. following meeting. The meeting will be prepared by the Federal Emergency
Date: September 6, 2017. closed to the public in accordance with Management Agency (FEMA) for each
Closed: 9:00 a.m. to 10:15 a.m. the provisions set forth in sections community, is appropriate because of
Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., new scientific or technical data. The
applications and/or proposals. FIRM, and where applicable, portions of
as amended. The grant applications and
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive the discussions could disclose the FIS report, have been revised to
Boulevard, Rockville, MD 20852. confidential trade secrets or commercial reflect these flood hazard
Open: 10:30 a.m. to 5:00 p.m. property such as patentable material, determinations through issuance of a
Agenda: This portion of the meeting will and personal information concerning Letter of Map Revision (LOMR). The
be open to the public for announcements and individuals associated with the grant LOMR will be used by insurance agents
mstockstill on DSK30JT082PROD with NOTICES
reports of administrative, legislative, and applications, the disclosure of which and others to calculate appropriate flood
program developments in the drug abuse would constitute a clearly unwarranted insurance premium rates for new
field. buildings and the contents of those
Place: National Institutes of Health,
invasion of personal privacy.
Neuroscience Center, 6001 Executive Name of Committee: Center for Scientific buildings. For rating purposes, the
Boulevard, Rockville, MD 20852. Review Special Emphasis Panel, PAR Panel: currently effective community number
Contact Person: Susan R.B. Weiss, Ph.D., Linking Provider Recommendation to is shown in the table below and must be
Director, Division of Extramural Research, Adolescent HPV Uptake. used for all new policies and renewals.
VerDate Sep<11>2014 17:15 Aug 14, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/82_FR_38853/page/1.svg)
Document Created: 2017-08-15 01:12:30
Document Modified: 2017-08-15 01:12:30
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | September 6, 2017. | |
| FR Citation | 82 FR 38697 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR